Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 10-2010 | 12-2009 | 10-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,208 | -59 | 0 | -17 | 0 |
| Depreciation Amortization | 6 | 1 | 0 | 1 | 0 |
| Accounts payable and accrued liabilities | 676 | N/A | 0 | N/A | 0 |
| Other Working Capital | 642 | 57 | N/A | 1 | N/A |
| Other Operating Activity | -656 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-539 | $0 | $0 | $-15 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | N/A | 0 | N/A | 0 |
| Investing Cash Flow | $-30 | $N/A | $0 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 225 | 1 | 0 | 12 | 0 |
| Debt Repayment | -100 | N/A | 0 | N/A | 0 |
| Other Financing Activity | 490 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $615 | $1 | $0 | $12 | $0 |
| Beginning Cash Position | 1 | 0 | 0 | 3 | 0 |
| End Cash Position | 48 | 1 | 0 | 0 | 0 |
| Net Cash Flow | $46 | $1 | $0 | $-3 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -539 | 0 | 0 | -15 | 0 |
| Capital Expenditure | -30 | N/A | 0 | N/A | 0 |
| Free Cash Flow | -569 | 0 | 0 | -15 | 0 |